Free alerts

AKTS insider buying

Every open-market purchase of Aktis Oncology, Inc. (AKTS) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$114.31M
Insiders buying (12m)6
Purchases on record6
Last purchase filedJan 14, 2026

In the last 12 months, 6 insiders of Aktis Oncology, Inc. bought $114.31M of AKTS stock on the open market in 6 reported purchases. The most recent was filed on Jan 14, 2026: Foley Todd (Director, 10% Owner) bought 232,870 shares at $18.00, worth $4.19M. The largest purchase on record here is $40M by Nodelman Oleg +1 on Jan 12, 2026.

Get the next AKTS insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All AKTS insider purchases

FiledInsiderValueSharesPriceStakeTrade
Jan 14Foley ToddDirector, 10% Owner$4.19M232,870$18.00+6%Jan 12SEC
Jan 14Mpm Oncology Innovations Fund…10% Owner$20.03M1,112,777$18.00+12%Jan 12SEC
Jan 14Gadicke Ansbert +210% Owner$20.03M1,112,777$18.00+12%Jan 12SEC
Jan 12Vida Ventures II-A, LLC +110% Owner$15.03M835,000$18.00+17%Jan 12SEC
Jan 12Kim Helen SusanDirector, 10% Owner$15.03M835,000$18.00+17%Jan 12SEC
Jan 12Nodelman Oleg +1Director$40M2,222,222$18.00newJan 12SEC